Erleada 60 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F20SY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,932
Award facts
- Contract value 100% obligated
- $15,931.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,931.60 to AmerisourceBergen Drug Corp for 120 units of Erleada 60 mg tablets, with a completion date of February 5, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Erleada (apalutamide) is a prescription medication used in the treatment of prostate cancer, reflecting the pharmaceutical distribution services that AmerisourceBergen provides to federal healthcare systems.
This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and other federal medical institutions worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to efficiently fulfill government pharmaceutical procurement requirements across multiple therapeutic domains in support of military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F20SY?
SPE2DR26F20SY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F20SY worth?
The government has obligated $15,932 on SPE2DR26F20SY.
Is contract SPE2DR26F20SY an order under another contract?
Yes. SPE2DR26F20SY is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20SY competed?
The extent of competition for SPE2DR26F20SY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award